MAGIC

@magic-horizon.bsky.social

24 Followers 34 Following

Accelerating the development of gene therapies for muscular dystrophies. Funded by @horizoneu.bsky.social, @ukri.org and Swiss State Secretariat for Education, Research and Innovation (SERI)

Three women in front of a banner from OPTICS11 Life
Image of a microscope and text "New MAGIC project publication. CRISPR-Cas9-mediated upregulation of utrophin ameliorates Duchenne muscular dystrophy"
Image of a person presenting at a conference with the text "conference insights, lay summaries now available"
Text which says "Scaling AAV Manufacturing for Neuromuscular Gene Therapy" alongside an image on an AAV
Rare disease day with the MAGIC team. Images of several MAGIC members who shared their thoughts
Crowd of people from the JP Morgan conference sat outside
Person stood in front of a screen presenting about AAV vectors and the MAGIC project
Map of the world with pins where MAGIC is located - America, UK, Ireland, Spain, Portugal, Germany, Italy, Netherlands and more
2026 written with a DNA strand coming out the 0
Image of a phone with the MAGIC newsletter on it, surrounded by notebooks and coffee cup
A laptop with notebooks next to the MAGIC, EU horizon, UKRI and SERI logos
Group of people from the MAGIC project standing on stairs.
A panel of people discussing the future of gene therapy in front of a crowd of people sitting down.
Group of people sat in front of two people presenting, with a screen in the background which says "why are we here?"
Person standing up in front of a podium speaking to a group of people sat down.
Images of 3 different presenters standing in front of their posters at ESGCT 2025
Marco Wachowius from DINAMIQS stands in front of the poster titled "Single-Particle Analysis of AAV Vectors by Mass Photometry: Insights into Packaging Efficiency and Stability"
Image of Francesco Saverio Tedesco in front of a crowd with a slide showing the MAGIC team
Check out MAGIC presentations! WMS 10:00 - 10:15 10 October Francesco Saverio Tedseco Towards a human multi-organoid platform to develop and assess specificity, toxicity and efficacy of neuromuscular gene therapies Posters at ESGCT P0287 - Mariam Zhouhair P0010 - Sumitava Dastidar P0373 - Leah Zerlin
Image of Vienna and Seville with the test overlayed: MAGIC is attending WMS and ESGCT next week.
Image of a person holding a pipette, next to text which says: "Can one platform capture the complexity of multiple neuromuscular conditions? Scalable and reproducible 3D muscle models."
Two scientists in the lab looking at a computer
Image of researcher in lab wearing gloves and holding a pipette. Text next to it "How we we improve the likelihood that gene therapies will succeed in clinical trials? Advanced 3D muscle models for better prediction"
Laptop and notebooks next to MAGIC project logo
Hands wearing gloves, holding a pipette in a fumehood
Image of Mariam Zouhair and a quote "I'm excited to be part of a project that brings together different perspectives and expertise to tackle such an important challenge."
Graphic which says "stay informed on the latest advancements in muscular dystrophy treatments"
Image of a computer and notebooks alongside the MAGIC logo
Image of Professor Karen English alongside text Meet the MAGIC project members, Professor Karen English, Maynooth University
Image of a person wearing gloves and a lab coat, using a pipette in a laboratory
Stay informed on the latest advancements in muscular dystrophy treatments
Image of Eduard Ayuso wearing a lab coat in the lab. Quote "Together, we can turn cutting-edge research into real-world treatments that have a lasting impact."
Two researchers in a laboratory looking at a computer
Image of two people involved in the MAGIC project with text "meet the experts behind the MAGIC project"
Accelerate genetic therapy development to impact the lives of people with muscular dystrophy
Meet the MAGIC Project members Image of Professor Frederic Relaix, Universite Paris-Est Creteil Val de Marne (UPEC)
A group of people stood together